Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid

Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid The Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Program (NTEP), Mylan said in a statement.

No comments:

Post a Comment